Companies researching CAR-T Cell Therapy
CAR‑T cell therapy engineers a patient's T cells to express chimeric antigen receptors, enabling them to identify and eliminate cancer cells, and is often classified as a cell‑based gene therapy.
658
companies
List of companies that research CAR-T Cell Therapy
This is sourced from job postings — companies only hire for what they actively use or plan to adopt · how we source this →

Employees138kRevenue$94BHospitals and Health Care
CAR-T Cell TherapyHigh confidence
Employees39kRevenue$46BPharmaceutical Manufacturing
CAR-T Cell TherapyHigh confidence
Employees18kRevenue$5.1BHigher Education
CAR-T Cell TherapyHigh confidence
Employees4.1kRevenue$45MBiotechnology Research
CAR-T Cell TherapyHigh confidence
Employees193kRevenue$105BHospitals and Health Care
CAR-T Cell TherapyHigh confidence
Employees21kRevenue$3.8BHospitals and Health Care
CAR-T Cell TherapyHigh confidence
Employees15kRevenue$27BBiotechnology Research
CAR-T Cell TherapyHigh confidence
Employees4.2kRevenue$500MHospitals and Health Care
CAR-T Cell TherapyHigh confidence
Employees13kRevenue$2.4BHospitals and Health Care
CAR-T Cell TherapyHigh confidence
Employees77kPharmaceutical Manufacturing
CAR-T Cell TherapyHigh confidence
Showing top companies out of 658 that research CAR-T Cell Therapy. Get the full list on TheirStack.
Frequently asked questions